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Abstract
Purpose To investigate the clinical and functional aspects of
MST1 (STK4) deficiency in a profoundly CD4-lymphopenic
kindred with a novel homozygous nonsense mutation in
STK4. Although recent studies have described the cellular
effects of murine Mst1 deficiency, the phenotype of MST1-
deficient human lymphocytes has yet to be fully explored.
Patient lymphocytes were therefore investigated in the context
of current knowledge of murine Mst1 deficiency.
Methods Genetic etiology was identified by whole exome se-
quencing of genomic DNA from two siblings, combined with
linkage analysis in the wider family. MST1 protein expression
was assessed by immunoblotting. The ability of patient lym-
phocytes to adhere to ICAM-1 under flow conditions was
measured, and transwell assays were used to assess chemo-
taxis. Chemokine receptor expression was examined by flow
cytometry and receptor signalling by immunoblotting.
Results A homozygous nonsense mutation in STK4
(c.442C > T, p.Arg148Stop) was found in the patients, leading
to a lack of MST1 protein expression. Patient leukocytes ex-
hibited deficient chemotaxis after stimulation with CXCL11,
despite preserved expression of CXCR3. Patient lymphocytes
were also unable to bind effectively to immobilised ICAM-1
under flow conditions, in keeping with a failure to develop
high affinity binding.
Conclusion The observed abnormalities of adhesion and mi-
gration imply a profound trafficking defect among human
MST1-deficient lymphocytes. By analogy with murine Mst1
deficiency and other defects of leucocyte trafficking, this is
likely to contribute to immunodeficiency by impairing key
aspects of T-cell development and function such as positive
selection in the thymus, thymic egress and immune synapse
formation in the periphery.
Keywords Combined immunodeficiency .MST1 . STK4 .
lymphocyte adhesion . chemotaxis . CD4 lymphopenia
Introduction
Primary immunodeficiencies (PIDs) are rare, inherited dis-
eases characterised by the altered function or absence of im-
mune cells. Recently, whole exome sequencing (WES) has
emerged as a powerful tool for revealing the genetic etiology
of certain PIDs. The benefits of this approach include the
potential discovery of novel disease-associated genes, and
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the relatively efficient identification of novel variants within
genes already known to be associated with PIDs. This work
describes an example of the latter, specifically the discovery of
a novel variant in the serine threonine kinase 4 (STK4) gene.
STK4 encodes a 63kD protein known as MST1, a mamma-
lian orthologue of the Drosophila Hpo protein, and a member
of a family of kinases related to the yeast protein Ste20 (sterile
20) [1]. Soon after its discovery, MST1 was identified as hav-
ing roles in regulation of apoptosis and proliferation [2, 3],
with other Ste20-like kinases found to have roles in cytoskel-
etal rearrangement [4]. The role of MST1 in cell death is
controversial, with both proapoptotic [5] and antiapoptotic
[6] functions claimed, although MST1 deficiency has been
associated with increased apoptosis in both mouse [7, 8] and
human [9, 10]. MST1 is also a signalling intermediate in the
process of ‘inside-out’ signalling in murine lymphocytes,
converting signals initiated by chemokine stimulation into
subsequent LFA-1 integrin activation and polarization [11,
12]. MST1 carries out this function by acting downstream of
Rap1, a small GTPase that becomes active after ligation of
chemokine receptors. Rap1 in turn binds RAPL, which binds
to MST1. This complex then mediates the activation and po-
larization of the LFA-1 integrin, and localises with LFA-1 at
the leading edge of the cell [12]. The surface redistribution of
active LFA-1 is vital for transendothelial migration of lympho-
cytes, as well as for the formation of the immune synapse [13,
14].
Recently, two studies have identified MST1 deficiency as
the cause of combined immunodeficiency (CID) in three dif-
ferent families with homozygous nonsense mutations in the
STK4 gene [9, 10]. This invariably resulted in profound CD4
lymphopenia and an accompanying phenotype of multiple
bacterial and viral infections, and mucocutaneous candidiasis
[15]. Here, we describe a further family with a biallelic STK4
mutation and similar clinical features. Further analysis of pa-
tient cells revealed a defect in LFA-1-mediated adhesion and
chemotaxis.
Case Study
We studied three siblings with early childhood onset of CID
characterized by CD4 lymphopenia and marked susceptibility
to opportunistic and bacterial infection. The index patient (P2)
was evaluated immunologically at 3 years of age following an
episode of lobar pneumonia from which she had failed to
recover fully. Her history was remarkable for a prior episode
of viral laryngotracheobronchitis requiring intubation and
ventilation, recurrent suppurative otitis media and eczema;
she experienced severe primary herpetic gingivostomatitis,
had ongoing chronic molluscum contagiosum and proved to
be consistently EBV-viremic. Her elder sister P1 had a similar
history of recurrent respiratory infection, molluscum and
ongoing EBV-viremia when assessed in middle childhood.
Both sisters also had documented cryptosporidiosis on more
than one occasion and both ultimately developed EBV-
associated lymphoproliferative disease, treated with
Rituximab and steroids before stem cell transplantation.
Their sister P3 was transplanted at a younger age because of
a similar infection history (molluscum, history of severe pri-
mary HSV, recurrent herpes zoster) and the availability of a
matched family donor. She developed florid cryptosporidial
diarrhea on day 0 of transplant, most likely representing the
recrudescence of chronic infection. After a stormy peri-
transplant period with veno-occlusive disease, capillary leak
and GVHD, she engrafted but had not immune reconstituted
when she acquired primary CMVand went on to develop fatal
immune dysregulation. P1 also succumbed to transplant-
related complications in the form of a cerebrovascular acci-
dent shortly after conditioning, while P2 has had a good out-
come from HSCT.
Laboratory work-up in all three children (Table 1) was
remarkable for CD4 lymphopenia, absence of naïve T cells
and hypergammaglobulinemia (yet low IgG2 and poor pneu-
mococcal responses) without evidence of autoimmunity.
Thymic size was normal on computer tomographic imaging
(data not shown). Given this clinical picture and a consanguin-
eous background (Fig. 1a), a leaky form of autosomal reces-
sive severe combined immunodeficiency was suspected but
known defects were ruled out by a negative genetic screen.
Homozygosity mapping was therefore undertaken, followed
by WES of two of the three patients. This led to the identi-
fication of a novel homozygous nonsense variant (c.
442C > T, p. Arg148Stop) in STK4, encoding MST1, that
was confirmed to segregate with disease in the family by
Sanger sequencing (Fig. 1b). Western blot analysis of pa-
tient fibroblast and lymphoblastoid B cell lysates con-
firmed loss of MST1 protein expression and hence the
diagnosis of MST1 deficiency (Fig. 1c).
Confidence in the disease-causing nature of this variant
was increased by the publication of two independent reports
linking loss-of-function STK4 mutations to CID [9, 10].
MST1 deficiencywas suggested to cause progressive lympho-
penia due to the anti-apoptotic role of the enzyme, but the
reduced adhesive and chemotactic potential found in murine
Mst1−/− lymphocytes [11, 13, 14, 16] was not fully explored in
their human equivalents.
Prior to the investigation of the adhesive and chemotactic
properties of patient peripheral blood leukocytes (PBLs), the
chemokine receptor expression of these cells was investigated
using flow cytometry. Expression of CXCR3 – a receptor for
CXCL11 – was observed in patient CD4+ T lymphocytes
(Fig. 2a), along with expression of CCR1, CCR2, CCR3,
CCR5, CCR6, CCR7, CXCR1, and CXCR5, and slightly re-
duced expression of CCR9 and CXCR4 (data not shown).
Due to the robust expression of CXCR3 by patient cells, the
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CXCL11-CXCR3 pathway was chosen for subsequent exper-
iments to investigate chemokine responses.
Assessment of ERK1/2 and AKT phosphorylation by
Western blot of patient EBV-transformed B-cell lysates dem-
onstrated an intact cellular response to CXCL11 stimulation
when compared to control EBV-transformed B-cell lysates
(Fig. 2b). These data confirm that chemokine receptor signal-
ling upstream of these proteins is preserved.
The ability of both patient EBV-transformed B cells and
patient PBLs to bind to surfaces under flow conditions was
investigated using a microfluidic system (Cellix VenaFlux
platform). Patient and control cells were exposed to a chip
coated with ICAM-1, with or without CXCL11 stimulation,
and adhered cells were counted. Control EBV-transformed B
cells exhibited a significant positive change in adhesiveness
upon stimulation with CXCL11, with the mean cell count
increasing from 24.3 to 45.5 (Fig. 2c left panel; n = 6,
P = 0.0313). Conversely, patient EBV-transformed B cells
underwent no significant change in adhesiveness in response
to the same chemokine, with the mean cell count decreasing
from 20.2 to 19.0 (n = 6). Similar data were obtained using
patient and control primary PBLs, although this experiment
Table 1 Clinical features and





Feature P1 P2 P3 Normal range
Clinical features
Eczema & skin infections + + −
Recurrent sinopulmonary infection + + −
Oral candidiasis − + −
Cryptosporidiosis + + +
Viral infections:
Molluscum contagiosum + + +
Recurrent VZV − − +
Severe 1° HSV + + −
Chronic EBV viremia + + +
EBV LPD + + −
Flow cytometric immunophenotyping (absolute cell counts per μl except where % indicated)
CD3+ T cells 815 850 921 1400–8000
CD4+ T cells *naive CD4+ T cells 2000 26,817 36,818 900–5500
CD8+ T cells *naïve CD8+ T cells 51,216 59,217 52,328 400–2300
TCR-γδ+ (% of T cells) 28 7 15
HLA-DR+ (% of T cells) 84 77 62
CD16+/CD56+ NK cells 192 147 298 100–1400
CD19+ B cells 439 897 1355 600–3100
CD27+IgD− (% of B cells) 2 3 5
Lymphocyte proliferation assay
PHA patient (cpm) 11,326 34,343 67,254
PHA control (cpm) 148,110 122,215 101,164
SI patient 82 29 94
SI control 445 407 349
Immunoglobulins
IgG 18.3 28.8 17.8 3.0–13.3 g/L
IgA 2.2 4.47 0.7 0.3–1.29 g/L
IgM 0.6 1.13 0.9 0.43–1.9 g/L
Pneumococcal ab <3 17 88 20–200 mg/L
Tetanus ab 0.88 1.55 0.49 0.1–10 IU/ml
Hemophilus B ab NT >9.0 NT 1.0–20 mg/L
VZV Varicella zoster virus, HSV Herpes simplex virus, EBV Epstein Barr Virus, LPD lymphoproliferative
disease, PHA phytohemagglutinin, cpm counts per minute, SI stimulation index, ab specific antibody, NT not
tested
a Laboratory evaluation was performed at 5.5 yrs. (P1), 3.4 yrs. (P2), 1.7 yrs. (P3)
b Naïve T cells were defined as CD3 + CD27 + CD45RA+ and as either CD4+ or CD4-
c Normal ranges are age matched to P3
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could only be carried out once with patient cells due to lack of
patient material (right panel). These data suggest that MST1-
deficient human lymphocytes are unable to respond to chemo-
kine stimulation by increasing adhesive potential in the same
way as control human lymphocytes.
In view of this impaired adhesive response to chemokine,
the chemotactic ability of primary patient cells was assessed
by performing transwell chemotaxis assays (Fig. 2d). Upon
addition of 24 nM CXCL11, control PBLs exhibited a 2 fold-
increase in the number of cells in the lower compartment
when compared to unstimulated cells. In comparison, migra-
tion of patient PBLs was unaltered after the addition of 24 nM
CXCL11 (note that this experiment could only be carried out
once due to lack of patient material). These data suggest that
MST1-deficient patient PBLs are impaired in their chemotac-
tic response to chemokine stimulation. This is consistent with
mouse data that demonstrate a role for MST1 in lymphocyte
chemotaxis [11].
Together, these observations therefore emphasise the con-
served role of MST1 in murine and human lymphocyte adhe-
sion and trafficking [11–14, 17], and offer a novel perspective
on the phenotype described in these patients.
Discussion
CID is a group of immunodeficiencies with diverse genetic
etiologies. Recent studies have identified biallelic mutations in
STK4 as a cause of CID. Nehme et al. [10] described two
families: the first containing one patient with a homozygous
SNP (c.C349T) leading to a premature stop codon
(p.Arg117Stop), and the second containing three siblings with
a homozygous single base deletion (c.T1103del) resulting in a
frameshift and a premature stop codon at position 369 of the
MST1 protein. Abdollahpour et al. [9] described three patients
(two siblings and their niece) in one family, all with a homo-
zygous SNP (c.G750A) leading to a premature stop codon
(p.Trp250Stop). More recently still, a report by Halacli et al.
[18] was published detailing a fourth MST1-deficient kindred
from Turkey featuring a novel 4 bp deletion in STK4 (c.58-
61delATAG) that results in a premature stop codon.
This study describes a fifth kindred with a different homo-
zygous STK4 mutation (c. 442C > T, p. Arg148Stop),
resulting in absent MST1 protein expression and profound
CD4 lymphopenia. The overall clinical picture described here
is similar to previous reports, with both sinopulmonary infec-
tions and abnormal herpesviral handling including EBV-
related lymphoproliferative disease. While autoimmune com-
plications, absent from our patients, were described by Halacli
et al. in two patients and Nehme et al. in two of four patients
[10], Abdollahpour et al. found no consistent evidence of au-
toimmunity [9]. The novel finding of cryptosporidiosis in all
three affected members of the present kindred is entirely con-
sistent with severely compromised T-cell function.
MST1 deficiency is a primary immunodeficiency that has
overlapping but not identical clinical features with other PIDs
involving defects in actin cytoskeletal reorganization. MST1
deficiency shares with DOCK8 deficiency and Wiskott-
Aldrich Syndrome (WAS) the occurrence of skin abscesses
and superficial infections with bacterial (Staphylococcus
aureus), viral (Molluscum contagiosum, Herpes simplex,
Varicella zoster and Human papilloma virus) and fungal
(Candida albicans) pathogens. Furthermore, recurrent respi-
ratory infections and bronchiectasis, as well as T-cell lympho-
penia and reduced in vitro T-cell proliferation, are part of all
three diseases. Autoimmunity may be a feature of both MST1
deficiency and WAS, in particular autoimmune haemolytic
anaemia, thrombocytopenia and neutropenia. Highly elevated
serum IgE levels, atopic manifestations such as severe eczema
and allergies, and failure to thrive distinguish DOCK8 defi-
ciency and WAS from MST1 deficiency. In addition to these
features, marked hypereosinophilia is suggestive of DOCK8
deficiency, whereas microthrombocytopenia in a male is typ-
ical for WAS [19, 20]. Thus, when patients exhibit marked
CD4 lymphopenia and susceptibility to infections in the ab-
sence of a bleeding disorder, MST1 deficiency should be con-




Fig. 1 a Pedigree of affected family, demonstrating consanguinity
(double horizontal lines). Males and females are indicated by squares
and circles respectively, with open symbols indicating healthy
individuals and shaded symbols indicating affected individuals.
Triangles indicate unaffected individuals with censored gender, and
diagonal lines indicate deceased individuals. b Sanger sequencing of
STK4 gene confirmed WES findings – a homozygous C to T
substitution at position 442 in patients that was heterozygous in both
parents. cWestern blotting of P3-derived EBV-transformed B cell lysate
and P1 and P3 fibroblast lysates, demonstrating MST1 deficiency.
Control lysates were derived from random healthy individuals.
Representative of a minimum of two separate experiments
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differential diagnosis for CD4 lymphopenia with EBV lym-
phoproliferative disease are autosomal recessive abnormali-
ties of T-cell signalling such as ITK and CD27 deficiencies,
as well as the X-linked disorder XMEN (MAGT1 deficiency)
[21]. Clinically, these disorders and MST1 deficiency may
behave very similarly. A thorough diagnostic work-up includ-
ing molecular genetic testing is advised to inform decision-
making around stem cell transplantation, which will often be
required.
The cellular phenotype of MST1-deficient human lympho-
cytes was explored in this study. Patient EBV-transformed B
cells and PBLs exhibited reduced LFA-1-dependent adhesive-
ness, and patient PBLs showed reduced transwell migration
after chemokine stimulation, when compared to control cells.
Nehme et al. also investigated a potential migratory defect in
MST1-deficient patient cells by using transwell assays, and
found that chemotaxis in response to CCL19 and CCL21 was
impaired, although this was attributed to the observed
reduction in expression of CCR7 – consistent with the absence
of naïve T cells [10]. In contrast, the present study shows a
chemotactic defect despite preserved expression of the rele-
vant chemokine receptor. Moreover, patient cells retained their
ability to phosphorylate ERK1/2 and AKT in response to che-
mokine stimulation, indicating intact or even augmented
outside-in signaling. In the mouse, inside-out signalling via
Mst1/Rap1/RAPL is vital for the stable arrest of lymphocytes
on endothelial surfaces [11] and for immune synapse forma-
tion [13]; we therefore speculate that human MST1 performs
the same function, which was disrupted in patient cells.
Both Abdollahpour et al. and Nehme et al. investigated the
apoptotic potential of lymphocytes from MST1-deficient pa-
tients [9, 10]. This was not an area of primary focus within this
study, although levels of apoptosis in resting control and pa-
tient EBV-transformed B cells were assessed and no consis-
tent difference was found. Recent studies have also suggested




Fig. 2 a Patient CD4+ T lymphocytes exhibit expression of the CXCL11
receptor CXCR3 (red histogram = unstained control, green histogram =
anti-CXCR3-PE antibody) (n = 1). b EBV-transformed B cells were
treated with 12 nM CXCL11 to stimulate CXCR3 before whole cell
lysis, Western transfer analysis and probing for phospho-ERK, total
ERK, phospho-AKT and total AKT, with β-tubulin as a loading
control. Numbers indicate time (mins) of treatment with CXCL11.
Representative of three separate experiments. c CXCL11 treated patient
EBV-transformed B cells (left panel) show reduced binding to ICAM-1-
coated chips under flow conditions when compared to control cells (*
indicates P = 0.0313). Patient PBLs also show reduced binding when
compared to control cells (right panel). Each shape represents one of six
separate experiments, with 5 replicates for each. Significance was
determined using Wilcoxon signed rank tests. d CXCL11-treated
patient PBLs show unchanged capacity for migration across transwell
filters when compared to control cells (n = 1)
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evidence regarding its precise role is conflicting [22–24]. In
future, the autophagic potential of primary MST1-deficient
human cells should be investigated, as this may contribute to
the immune phenotype seen here.
Our data reinforce previous findings in mice that suggest a
role for MST1 in LFA-1 activation and polarization [17] and
extend these findings to human disease. This reduction in
lymphocyte binding potential has ramifications for many im-
mune processes, which likely contributes to the profound phe-
notype seen in MST1-deficient patients. The relationship be-
tween increased apoptosis and decreased lymphocyte adhe-
sion merits further study.
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